IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Blood Cells, Molecules, and Diseases

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.79

h-Index

2022-2023

 95

Rank

2022-2023

 6892

SJR

2022-2023

 0.718

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Blood Cells, Molecules, and Diseases
Abbreviation Blood Cells Mol. Dis.
Publication Type Journal
Subject Area, Categories, Scope Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)
h-index 95
Overall Rank/Ranking 6892
SCImago Journal Rank (SJR) 0.718
Impact Score 1.79
Publisher Academic Press Inc.
Country United States
ISSN 10960961, 10799796
Best Quartile Q2
Coverage History 1995-2023




Aim and Scope


Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.


About Blood Cells, Molecules, and Diseases


Blood Cells, Molecules, and Diseases is a journal covering the technologies/fields/categories related to Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3). It is published by Academic Press Inc.. The overall rank of Blood Cells, Molecules, and Diseases is 6892. According to SCImago Journal Rank (SJR), this journal is ranked 0.718. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 95. The best quartile for this journal is Q2.

The ISSN of Blood Cells, Molecules, and Diseases journal is 10960961, 10799796. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Blood Cells, Molecules, and Diseases is cited by a total of 441 articles during the last 3 years (Preceding 2022).


Blood Cells, Molecules, and Diseases Impact IF 2022-2023


The Impact IF 2022 of Blood Cells, Molecules, and Diseases is 1.79, which is computed in 2023 as per its definition. Blood Cells, Molecules, and Diseases IF is decreased by a factor of 0.16 and approximate percentage change is -8.21% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Blood Cells, Molecules, and Diseases Impact IF 2023 Prediction


Impact IF 2022 of Blood Cells, Molecules, and Diseases is 1.79. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Blood Cells, Molecules, and Diseases. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.79
2021 1.95
2020 2.56
2019 2.07
2018 1.59
2017 1.63
2016 1.89
2015 2.55
2014 2.54

Blood Cells, Molecules, and Diseases h-index


  Table Setting

Blood Cells, Molecules, and Diseases has an h-index of 95. It means 95 articles of this journal have more than 95 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Blood Cells, Molecules, and Diseases ISSN


The ISSN of Blood Cells, Molecules, and Diseases is 10960961, 10799796. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Blood Cells, Molecules, and Diseases Rank and SCImago Journal Rank (SJR)


The overall rank of Blood Cells, Molecules, and Diseases is 6892. According to SCImago Journal Rank (SJR), this journal is ranked 0.718. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Blood Cells, Molecules, and Diseases by Year


Year SJR
2023/2024 Coming Soon
2022 0.718
2021 0.720
2020 0.844
2019 0.740
2018 0.696
2017 0.828
2016 0.935
2015 1.287
2014 1.083

Ranking of Blood Cells, Molecules, and Diseases by Year


Year Ranking
2023/2024 Coming Soon
2022 6892
2021 6604
2020 5612
2019 6517
2018 6904
2017 5590
2016 4823
2015 3064
2014 3842

Blood Cells, Molecules, and Diseases Publisher


Table Setting

Blood Cells, Molecules, and Diseases is published by Academic Press Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1995-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Blood Cells, Molecules, and Diseases is Blood Cells Mol. Dis.. This abbreviation ('Blood Cells Mol. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Blood Cells, Molecules, and Diseases


If your research field is/are related to Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Blood Cells, Molecules, and Diseases?

Blood Cells, Molecules, and Diseases latest impact IF is 1.79. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.56 (2020) and 1.59 (2018), respectively, in the last 9 years. Moreover, its average IS is 2.06 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases has an SJR (SCImago Journal Rank) of 0.718, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.287 in 2015 and the lowest being 0.696 in 2018. Furthermore, the average SJR of the Blood Cells, Molecules, and Diseases over the previous 9-year period stands at 2.06.


What's the latest h-index of the Blood Cells, Molecules, and Diseases?

The latest h-index of the Blood Cells, Molecules, and Diseases is 95.


Who's the publisher of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is published by the Academic Press Inc., with its country of publication being the United States.


What's the current ranking of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is currently ranked 6892 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3064 in 2015 and its lowest position of 6904 in 2018.


What's the abbreviation or short name for the Blood Cells, Molecules, and Diseases?

The standard ISO4 abbreviation for the Blood Cells, Molecules, and Diseases is Blood Cells Mol. Dis..


Is the "Blood Cells, Molecules, and Diseases" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Blood Cells, Molecules, and Diseases is classified as a journal that the Academic Press Inc. publishes.


What's the scope or major areas of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases encompasses the following areas:

  • Hematology
  • Cell Biology
  • Molecular Biology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is assigned the following International Standard Serial Numbers (ISSN): 10960961, 10799796.


What's the best quartile of the Blood Cells, Molecules, and Diseases?

The best quartile for the Blood Cells, Molecules, and Diseases is Q2 (2022).


What's the coverage history of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases coverage history can be summarized as follows: 1995-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
Proceedings of the International Symposium on Power Semiconductor Devices and ICs conference and proceedings 7015 49 2.14
Journal of Supply Chain Management journal 378 Wiley-Blackwell 104 12.58
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
Sapporo Medical Journal journal 20468 Cancer Research Institute, Sapporo Medical University 3 0.00
Population Review journal 17841 Sociological Demography Press 13 0.73
Oral Radiology journal 9461 Springer Japan 20 2.06
Journal des Professionnels de l'Enfance journal 27577 TPMA 2 0.00
Archiv fur Geflugelkunde journal 28770 Verlag Eugen Ulmer 30 0.00

Check complete list




Year wise Impact Score (IS) of Blood Cells, Molecules, and Diseases

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.79
2021 1.95
2020 2.56
2019 2.07
2018 1.59
2017 1.63
2016 1.89
2015 2.55
2014 2.54



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Cell Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Metabolism
Cell Press | United States

Nature Cell Biology
Nature Publishing Group | United Kingdom

Molecular Cell
Cell Press | United States

Genome Biology
BioMed Central Ltd. | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Annual Review of Plant Biology
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Cell Host and Microbe
Cell Press | United States

Cell Metabolism
Cell Press | United States

Molecular Cell
Cell Press | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All